name: sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating measurement


name: stromal interaction molecule 1 measurement

category: biolink:PhenotypicFeature biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:NamedThing biolink:ThingWithTaxon


name: stromal membrane-associated protein 1 measurement


name: structural maintenance of chromosomes protein 3 measurement


name: submaxillary gland androgen-regulated protein 3A measurement


name: sulfatase-modifying factor 1 measurement


name: SUN domain-containing protein 3 measurement


name: SUN domain-containing protein 5 measurement


name: suppressor of cytokine signaling 3 measurement


name: Sushi domain-containing protein 2 measurement


name: switch-associated protein 70 measurement


name: synaptotagmin-like protein 4 measurement


name: T-cell surface glycoprotein CD3 epsilon chain measurement


name: T-cell surface protein tactile measurement


name: t-SNARE domain-containing protein 1 measurement


name: testis-expressed sequence 29 protein measurement


name: testis-specific basic protein Y 1 measurement


name: testis-specific chromodomain protein Y 1 measurement


name: thioredoxin domain-containing protein 5 measurement


name: thioredoxin reductase 1, cytoplasmic measurement


name: thrombospondin type-1 domain-containing protein 1 measurement


name: toll/interleukin-1 receptor domain-containing adapter protein measurement


name: torsin-1A-interacting protein 1 measurement


name: transcription regulator protein BACH1 measurement


name: transferrin receptor protein 1 measurement


name: transformer-2 protein homolog beta measurement


name: translation initiation factor eIF-2B subunit alpha measurement


name: transmembrane emp24 domain-containing protein 10 measurement


name: transmembrane gamma-carboxyglutamic acid protein 1 measurement


name: transmembrane inner ear expressed protein measurement


name: transmembrane protease serine 11D measurement


name: transmembrane protein 59-like measurement


name: trem-like transcript 2 protein measurement


name: trem-like transcript 4 protein measurement


name: triggering receptor expressed on myeloid cells 1 measurement


name: tuberoinfundibular peptide of 39 residues measurement


name: tubulin polymerization-promoting protein family member 2 measurement


name: tubulin-specific chaperone A measurement


name: tubulin-specific chaperone E measurement


name: tumor necrosis factor receptor superfamily member 16 measurement


name: tumor protein p53-inducible protein 11 measurement


name: type 2 lactosamine alpha-2,3-sialyltransferase measurement


name: tyrosine-protein phosphatase non-receptor type 4 measurement


name: tyrosine-protein phosphatase non-receptor type 7 measurement


name: tyrosine-protein phosphatase non-receptor type 9 measurement


name: tyrosine-protein phosphatase non-receptor type substrate 1 measurement


name: U1 small nuclear ribonucleoprotein A measurement


name: ubiquitin carboxyl-terminal hydrolase 21 measurement


name: ubiquitin carboxyl-terminal hydrolase 8 measurement


name: ubiquitin domain-containing protein 2 measurement


name: ubiquitin-conjugating enzyme E2 D4 measurement


name: ubiquitin-conjugating enzyme E2 variant 1 measurement


name: UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 measurement


name: uncharacterized family 31 glucosidase KIAA1161 measurement


name: uncharacterized protein C10orf35 measurement


name: uncharacterized protein C14orf93 measurement


name: uncharacterized protein C17orf78 measurement


name: uncharacterized protein C2orf66 measurement


name: uncharacterized protein C3orf18 measurement


name: uncharacterized protein C6orf226 measurement


name: uncharacterized protein C7orf69 measurement


name: uncharacterized protein KIAA0040 measurement


name: uncharacterized protein KIAA2013 measurement


name: unique cartilage matrix-associated protein measurement


name: UPF0577 protein KIAA1324-like measurement


name: UV excision repair protein RAD23 homolog B measurement


name: vacuolar protein sorting-associated protein 29 measurement


name: vacuolar protein sorting-associated protein 4A measurement


name: vacuolar protein sorting-associated protein 4B measurement


name: very long-chain acyl-CoA synthetase measurement


name: vesicle transport through interaction with t-SNAREs homolog 1B measurement


name: vesicle-associated membrane protein-associated protein A measurement


name: voltage-dependent calcium channel subunit alpha-2/delta-3 measurement


name: voltage-gated potassium channel subunit beta-2 measurement


name: WAP four-disulfide core domain protein 3 measurement


name: WD repeat-containing protein 1 measurement


name: WSC domain-containing protein 2 measurement


name: xyloside xylosyltransferase 1 measurement


name: zona pellucida sperm-binding protein 4 measurement


name: 17-beta-hydroxysteroid dehydrogenase 14 measurement


name: 26S proteasome non-ATPase regulatory subunit 4 measurement


name: 4-hydroxy-2-oxoglutarate aldolase, mitochondrial measurement


name: 72 kDa inositol polyphosphate 5-phosphatase measurement


name: a disintegrin and metalloproteinase with thrombospondin motifs 3 measurement


name: acidic leucine-rich nuclear phosphoprotein 32 family member A measurement


name: actin-related protein 2/3 complex subunit 3 measurement


name: activator of apoptosis harakiri measurement


name: adenylosuccinate synthetase isozyme 1 measurement


name: adenylyltransferase and sulfurtransferase MOCS3 measurement


name: alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C measurement


name: amyloid beta A4 precursor protein-binding family B member 1 measurement


name: amyloid beta A4 precursor protein-binding family B member 3 measurement


name: angiogenic factor with G patch and FHA domains 1 measurement


name: angiopoietin-related protein 7 measurement


name: ankyrin repeat domain-containing protein 27 measurement


name: arginine/serine-rich protein 1 measurement


name: armadillo repeat-containing protein 5 measurement


name: ATP-dependent DNA helicase Q1 measurement


name: ATP-dependent RNA helicase A measurement


name: ATP-dependent RNA helicase DDX25 measurement


name: ATPase family AAA domain-containing protein 1 measurement


name: B-cell receptor-associated protein 29 measurement


name: BAG family molecular chaperone regulator 3 measurement


name: BAG family molecular chaperone regulator 4 measurement


name: BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 measurement


name: beta-1,3-N-acetylglucosaminyltransferase manic fringe measurement


name: bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1 measurement


name: BPI fold-containing family A member 1 measurement


name: BRCA1-associated RING domain protein 1 measurement


name: bromodomain testis-specific protein measurement


name: BTB/POZ domain-containing protein KCTD5 measurement


name: C-type lectin domain family 2 member A measurement


name: C-type lectin domain family 2 member L measurement


name: C-type lectin domain family 4 member D measurement


name: C-type lectin domain family 6 member A measurement


name: C-type lectin domain family 7 member A measurement


name: cadherin-related family member 3 measurement


name: calcineurin B homologous protein 1 measurement


name: calcineurin B homologous protein 3 measurement


name: calcium uptake protein 3, mitochondrial measurement


name: calcium-binding and coiled-coil domain-containing protein 2 measurement


name: carbohydrate sulfotransferase 14 measurement


name: carbohydrate sulfotransferase 5 measurement


name: carcinoembryonic antigen-related cell adhesion molecule 21 measurement


name: cas scaffolding protein family member 4 measurement


name: CCR4-NOT transcription complex subunit 1 measurement


name: cell cycle progression protein 1 measurement


name: cell differentiation protein RCD1 homolog measurement


name: cellular retinoic acid-binding protein 2 measurement


name: cerebral cavernous malformations 2 protein measurement


name: ceroid-lipofuscinosis neuronal protein 5 measurement


name: chloride intracellular channel protein 4 measurement


name: choriogonadotropin subunit beta variant 2 measurement


name: chromodomain-helicase-DNA-binding protein 7 measurement


name: chymotrypsin-like elastase family member 2A measurement


name: cilia- and flagella-associated protein 45 measurement


name: cocaine- and amphetamine-regulated transcript protein measurement


name: coiled-coil domain-containing protein 134 measurement


name: coiled-coil domain-containing protein 167 measurement


name: coiled-coil domain-containing protein 51 measurement


name: cold shock domain-containing protein C2 measurement


name: cold shock domain-containing protein E1 measurement


name: collagen alpha-1(XXVIII) chain measurement


name: COMM domain-containing protein 1 measurement


name: complement C1q tumor necrosis factor-related protein 3 measurement


name: complement component C1q receptor measurement


name: CUB domain-containing protein 1 measurement


name: cyclin-dependent kinase 2-associated protein 1 measurement


name: cyclin-dependent kinase 4 inhibitor B measurement


name: cyclin-dependent kinase inhibitor 3 measurement


name: cysteine and glycine-rich protein 2 measurement


name: cysteine--tRNA ligase, cytoplasmic measurement


name: cysteine-rich motor neuron 1 protein measurement


name: cytochrome b-c1 complex subunit 7 measurement


name: cytochrome c oxidase subunit 5B, mitochondrial measurement


name: cytochrome c oxidase subunit 7A1, mitochondrial measurement


name: cytokine receptor-like factor 1 measurement


name: DCC-interacting protein 13-alpha measurement


name: DDB1- and CUL4-associated factor 5 measurement


name: delta and Notch-like epidermal growth factor-related receptor measurement


name: deoxynucleoside triphosphate triphosphohydrolase SAMHD1 measurement


name: dihydrolipoyl dehydrogenase, mitochondrial measurement


name: dihydropyrimidinase-related protein 3 measurement


name: dihydropyrimidinase-related protein 5 measurement


name: disintegrin and metalloproteinase domain-containing protein 19 measurement


name: DNA dC->dU-editing enzyme APOBEC-3G measurement


name: DNA excision repair protein ERCC-1 measurement


name: DNA-directed DNA/RNA polymerase mu measurement


name: DnaJ homolog subfamily A member 4 measurement


name: DnaJ homolog subfamily B member 12 measurement


name: DnaJ homolog subfamily C member 10 measurement


name: DnaJ homolog subfamily C member 15 measurement


name: DnaJ homolog subfamily C member 4 measurement


name: dual specificity protein phosphatase 15 measurement


name: dual specificity protein phosphatase 16 measurement


name: dual specificity protein phosphatase 6 measurement


name: dynein light chain Tctex-type 3 measurement


name: dyslexia-associated protein KIAA0319-like protein measurement


name: E3 ISG15--protein ligase HERC5 measurement


name: E3 ubiquitin-protein ligase CCNB1IP1 measurement


name: E3 ubiquitin-protein ligase DTX1 measurement


name: E3 ubiquitin-protein ligase HECW1 measurement


name: e3 ubiquitin-protein ligase parkin measurement


name: e3 ubiquitin-protein ligase pellino homolog 2 measurement


name: E3 ubiquitin-protein ligase RNF114 measurement


name: E3 ubiquitin-protein ligase RNF149 measurement


name: E3 ubiquitin-protein ligase RNF34 measurement


name: ecto-NOX disulfide-thiol exchanger 2 measurement


name: ectonucleoside triphosphate diphosphohydrolase 6 measurement


name: EH domain-containing protein 4 measurement


name: electroneutral sodium bicarbonate exchanger 1 measurement


name: engulfment and cell motility protein 1 measurement


name: enhancer of mRNA-decapping protein 4 measurement


name: ES1 protein homolog, mitochondrial measurement


name: ETS-related transcription factor Elf-5 measurement


name: eukaryotic translation initiation factor 4 gamma 3 measurement


name: fas apoptotic inhibitory molecule 3 measurement


name: fibrinogen C domain-containing protein 1 measurement


name: fibronectin type III domain-containing protein 4 measurement


name: fragile X mental retardation syndrome-related protein 1 measurement


name: fructose-1,6-bisphosphatase isozyme 2 measurement


name: fructose-bisphosphate aldolase C measurement


name: g-protein coupled receptor 26 measurement


name: glioma pathogenesis-related protein 1 measurement


name: glucagon-like peptide 1 receptor measurement


name: glutathione S-transferase kappa 1 measurement


name: glutathione S-transferase theta-2B measurement


name: glycerophosphocholine phosphodiesterase GPCPD1 measurement


name: glycoprotein hormones alpha chain measurement


name: glycosyltransferase-like protein LARGE1 measurement


name: granulocyte-macrophage colony-stimulating factor receptor subunit alpha measurement


name: GRB2-related adapter protein measurement


name: grpE protein homolog 1, mitochondrial measurement


name: GSK3-beta interaction protein measurement


name: guanine nucleotide exchange factor DBS measurement


name: guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 measurement


name: heparan sulfate glucosamine 3-O-sulfotransferase 3B1 measurement


name: heparan sulfate glucosamine 3-O-sulfotransferase 4 measurement


name: high mobility group protein 20A measurement


name: histone deacetylase complex subunit SAP30 measurement


name: histone H2A deubiquitinase MYSM1 measurement


name: histone-lysine N-methyltransferase ASH1L measurement


name: histone-lysine N-methyltransferase SETD2 measurement


name: histone-lysine N-methyltransferase SETMAR measurement


name: histone-lysine N-methyltransferase SUV420H2 measurement


name: HLA class II histocompatibility antigen gamma chain measurement


name: ig Kappa chain V-I region HK102- like measurement


name: immunoglobulin superfamily member 8 measurement


name: inactive dipeptidyl peptidase 10 measurement


name: inactive ribonuclease-like protein 10 measurement


name: inositol-trisphosphate 3-kinase A measurement


name: insulin-induced gene 1 protein measurement


name: insulin-like growth factor-binding protein-like 1 measurement


name: integral membrane protein 2B measurement


name: interferon lambda receptor 1 measurement


name: interferon regulatory factor 9 measurement


name: interleukin enhancer-binding factor 3 measurement


name: interleukin-2 receptor subunit beta measurement


name: IQ domain-containing protein F1 measurement


name: iron-sulfur cluster assembly enzyme ISCU, mitochondrial measurement


name: kell blood group glycoprotein measurement


name: keratin, type I cytoskeletal 17 measurement


name: keratin, type II cytoskeletal 5 measurement


name: keratin, type II cytoskeletal 7 measurement


name: l-lactate dehydrogenase C chain measurement


name: leucine-rich repeat and calponin homology domain-containing protein 4 measurement


name: leucine-rich repeat and fibronectin type III domain-containing protein 1 measurement


name: leucine-rich repeat and fibronectin type-III domain-containing protein 2 measurement


name: leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 measurement


name: leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3 measurement


name: leucine-rich repeat and transmembrane domain-containing protein 1 measurement


name: leucine-rich repeat transmembrane neuronal protein 4 measurement


name: leucine-rich repeat-containing protein 4B measurement


name: leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 2 measurement


name: leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 3 measurement


name: leukocyte cell-derived chemotaxin 1 measurement


name: leukocyte immunoglobulin-like receptor subfamily B member 3 measurement


name: leukocyte-associated immunoglobulin-like receptor 1 measurement


name: leukocyte-specific transcript 1 protein measurement


name: linker for activation of T-cells family member 2 measurement


name: lymphocyte function-associated antigen 3 measurement


name: lysM and putative peptidoglycan-binding domain-containing protein 4 measurement


name: lysophospholipase-like protein 1 measurement


name: MAGUK p55 subfamily member 7 measurement


name: malonyl-CoA decarboxylase, mitochondrial measurement


name: MAM domain-containing protein 2 measurement


name: marginal zone B- and B1-cell-specific protein measurement


name: matrix-remodeling-associated protein 8 measurement


name: melanocortin-2 receptor accessory protein 2 measurement


name: melanoma-associated antigen B10 measurement


name: membrane magnesium transporter 1 measurement


name: membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 measurement


name: membrane-associated progesterone receptor component 1 measurement


name: methionine-R-sulfoxide reductase B3 measurement


name: methylmalonyl-CoA epimerase, mitochondrial measurement


name: microfibril-associated glycoprotein 4 measurement


name: microfibrillar-associated protein 5 measurement


name: mismatch repair endonuclease PMS2 measurement


name: mitochondrial fission regulator 1 measurement


name: multidrug resistance-associated protein 6 measurement


name: multiple epidermal growth factor-like domains protein 10 measurement


name: myc-associated zinc finger protein measurement


name: myocardial zonula adherens protein measurement


name: myocyte-specific enhancer factor 2C measurement


name: myosin-binding protein C, slow-type measurement


name: myotubularin-related protein 1 measurement


name: n-acetylglucosamine-1-phosphotransferase subunit gamma measurement


name: n-acetylglutamate synthase, mitochondrial measurement


name: NACHT, LRR and PYD domains-containing protein 1 measurement


name: natural cytotoxicity triggering receptor 3 ligand 1 measurement


name: neurofilament heavy polypeptide measurement


name: neuron-specific vesicular protein calcyon measurement


name: neuropilin and tolloid-like protein 1 measurement


name: NFU1 iron-sulfur cluster scaffold homolog, mitochondrial measurement


name: non-homologous end-joining factor 1 measurement


name: noncompact myelin-associated protein measurement


name: nuclear nucleic acid-binding protein C1D measurement


name: nuclear pore membrane glycoprotein 210-like measurement


name: nuclear receptor subfamily 5 group A member 2 measurement


name: o-acetyl-ADP-ribose deacetylase MACROD1 measurement


name: orexigenic neuropeptide QRFP measurement


name: ornithine decarboxylase antizyme 1 measurement


name: orphan sodium- and chloride-dependent neurotransmitter transporter NTT5 measurement


name: palmitoleoyl-protein carboxylesterase NOTUM measurement


name: PDZ and LIM domain protein 4 measurement


name: peptidyl-prolyl cis-trans isomerase FKBP2 measurement


name: peroxisome proliferator-activated receptor alpha measurement


name: phosphatidate phosphatase PPAPDC1A measurement


name: phosphatidylinositol 5-phosphate 4-kinase type-2 alpha measurement


name: phosphatidylinositol transfer protein alpha isoform measurement


name: phosphatidylinositol transfer protein beta isoform measurement


name: phosphoribosyl pyrophosphate synthase-associated protein 1 measurement


name: pleckstrin homology domain-containing family A member 1 measurement


name: polypeptide N-acetylgalactosaminyltransferase 11 measurement


name: polypeptide N-acetylgalactosaminyltransferase 3 measurement


name: potassium voltage-gated channel subfamily A member 10 measurement


name: potassium voltage-gated channel subfamily F member 1 measurement


name: potassium voltage-gated channel subfamily G member 4 measurement


name: PR domain zinc finger protein 4 measurement


name: pre-mRNA-processing factor 6 measurement


name: pregnancy-specific beta-1-glycoprotein 11 measurement


name: pregnancy-specific beta-1-glycoprotein 2 measurement


name: pregnancy-specific beta-1-glycoprotein 8 measurement


name: pro-neuregulin-2, membrane-bound isoform measurement


name: probable ATP-dependent RNA helicase DHX58 measurement


name: probable E3 ubiquitin-protein ligase HERC4 measurement


name: probable E3 ubiquitin-protein ligase MID2 measurement


name: probable G-protein coupled receptor 101 measurement


name: probable inactive ribonuclease-like protein 13 measurement


name: probable RNA-binding protein 19 measurement


name: procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 measurement


name: procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 measurement


name: prolyl 4-hydroxylase subunit alpha-1 measurement


name: prolyl 4-hydroxylase subunit alpha-2 measurement


name: prostate and testis expressed protein 1 measurement


name: proteasome assembly chaperone 3 measurement


name: proteasome subunit alpha type-4 measurement


name: proteasome subunit beta type-5 measurement


name: protein arginine N-methyltransferase 3 measurement


name: protein kinase C-binding protein NELL2 measurement


name: protein phosphatase 1 regulatory subunit 3B measurement


name: protein SCO1 homolog, mitochondrial measurement


name: protein transport protein Sec61 subunit gamma measurement


name: putative chondrosarcoma-associated gene 1 protein measurement


name: putative phospholipase B-like 2 measurement


name: putative pregnancy-specific beta-1-glycoprotein 7 measurement


name: pyruvate carboxylase, mitochondrial measurement


name: radiation-inducible immediate-early gene IEX-1 measurement


name: rap guanine nucleotide exchange factor 5 measurement


name: rap1 GTPase-GDP dissociation stimulator 1 measurement


name: receptor-interacting serine/threonine-protein kinase 2 measurement


name: receptor-type tyrosine-protein phosphatase eta measurement


name: receptor-type tyrosine-protein phosphatase R measurement


name: receptor-type tyrosine-protein phosphatase S measurement


name: receptor-type tyrosine-protein phosphatase U measurement


name: regulator of G-protein signaling 3 measurement


name: retina-specific copper amine oxidase measurement


name: retinoblastoma-like protein 1 measurement


name: rho GTPase-activating protein 1 measurement


name: rho GTPase-activating protein 36 measurement


name: rho GTPase-activating protein 5 measurement


name: rho guanine nucleotide exchange factor 2 measurement


name: rho guanine nucleotide exchange factor 25 measurement


name: rho guanine nucleotide exchange factor 7 measurement


name: rho-associated protein kinase 2 measurement


name: rho-related GTP-binding protein Rho6 measurement


name: rho-related GTP-binding protein RhoD measurement


name: ribosome biogenesis protein TSR3 homolog measurement


name: RNA binding protein fox-1 homolog 2 measurement


name: RNA polymerase II elongation factor ELL2 measurement


name: RUN and FYVE domain-containing protein 1 measurement


name: SAGA-associated factor 29 homolog measurement


name: SAYSvFN domain-containing protein 1 measurement


name: scavenger receptor class A member 3 measurement


name: secretory carrier-associated membrane protein 5 measurement


name: serine palmitoyltransferase 1 measurement


name: serine palmitoyltransferase 2 measurement


name: serine protease inhibitor Kazal-type 13 measurement


name: serine protease inhibitor Kazal-type 5 measurement


name: serine protease inhibitor Kazal-type 9 measurement


name: serine--tRNA ligase, mitochondrial measurement


name: serine/threonine-protein kinase BRSK2 measurement


name: serine/threonine-protein kinase DCLK3 measurement


name: serine/threonine-protein kinase ULK3 measurement


name: serine/threonine-protein kinase VRK1 measurement


name: serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform measurement


name: signal peptide, CUB and EGF-like domain-containing protein 1 measurement


name: signal-transducing adaptor protein 1 measurement


name: signaling lymphocytic activation molecule measurement


name: SLIT and NTRK-like protein 4 measurement


name: small conductance calcium-activated potassium channel protein 1 measurement


name: sodium channel subunit beta-2 measurement


name: sodium- and chloride-dependent glycine transporter 1 measurement


name: sodium-independent sulfate anion transporter measurement


name: soluble calcium-activated nucleotidase 1 measurement


name: solute carrier family 41 member 2 measurement


name: sperm-associated antigen 11B measurement


name: spermatogenesis-associated protein 9 measurement


name: splicing factor 3B subunit 4 measurement


name: splicing factor U2AF 65 kDa subunit measurement


name: sprouty-related, EVH1 domain-containing protein 1 measurement


name: SPRY domain-containing SOCS box protein 1 measurement


name: stromal cell-derived factor 2-like protein 1 measurement


name: suppressor of cytokine signaling 7 measurement


name: Sushi domain-containing protein 1 measurement


name: Sushi domain-containing protein 3 measurement


name: Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 measurement


name: SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related measurement


name: synaptic vesicle glycoprotein 2A measurement


name: synaptosomal-associated protein 29 measurement


name: synaptotagmin-like protein 1 measurement


name: t-box transcription factor TBX5 measurement


name: t-cell receptor-associated transmembrane adapter 1 measurement


name: t-cell surface glycoprotein CD3 gamma chain measurement


name: t-cell surface glycoprotein CD5 measurement


name: t-cell surface glycoprotein CD8 beta chain measurement


name: tetratricopeptide repeat protein 17 measurement


name: tetratricopeptide repeat protein 9B measurement


name: thioredoxin domain-containing protein 11 measurement


name: tissue factor pathway inhibitor 2 measurement


name: TNF receptor-associated factor 4 measurement


name: TOX high mobility group box family member 3 measurement


name: transcription regulator protein BACH2 measurement


name: transcriptional activator protein Pur-alpha measurement


name: transcriptional enhancer factor TEF-5 measurement


name: transcriptional regulator Kaiso measurement


name: translocon-associated protein subunit alpha measurement


name: transmembrane and coiled-coil domain-containing protein 5A measurement


name: transmembrane and ubiquitin-like domain-containing protein 2 measurement


name: transmembrane emp24 domain-containing protein 4 measurement


name: transmembrane protease serine 5 measurement


name: transmembrane protein C16orf54 measurement


name: trem-like transcript 1 protein measurement


name: tubulointerstitial nephritis antigen-like measurement


name: tuftelin-interacting protein 11 measurement


name: tumor necrosis factor alpha-induced protein 3 measurement


name: tumor necrosis factor receptor superfamily member 1A measurement


name: tumor susceptibility gene 101 protein measurement


name: twisted gastrulation protein homolog 1 measurement


name: type III endosome membrane protein TEMP measurement


name: tyrosine-protein kinase transmembrane receptor ROR2 measurement


name: tyrosyl-DNA phosphodiesterase 1 measurement


name: ubiquitin-conjugating enzyme E2 T measurement


name: UBX domain-containing protein 4 measurement


name: UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 measurement


name: UDP-glucuronic acid decarboxylase 1 measurement


name: uncharacterized protein C17orf67 measurement


name: uncharacterized protein C19orf18 measurement


name: uncharacterized protein C1orf115 measurement


name: uncharacterized protein C1orf185 measurement


name: uncharacterized protein C1orf198 measurement


name: uncharacterized protein C22orf15 measurement


name: v-set and immunoglobulin domain-containing protein 1 measurement


name: v-set and transmembrane domain-containing protein 4 measurement


name: vesicle transport through interaction with t-SNAREs homolog 1A measurement


name: vesicle-associated membrane protein 3 measurement


name: vesicle-associated membrane protein 4 measurement


name: vesicle-associated membrane protein 8 measurement


name: vesicle-associated membrane protein-associated protein B/C measurement


name: vesicle-trafficking protein SEC22a measurement


name: von Willebrand factor C domain-containing protein 2-like measurement


name: WAP four-disulfide core domain protein 10A measurement


name: WAP four-disulfide core domain protein 13 measurement


name: WAP four-disulfide core domain protein 5 measurement


name: YTH domain-containing protein 1 measurement


name: zona pellucida-like domain-containing protein 1 measurement


name: growth arrest and DNA damage-inducible proteins-interacting protein 1 measurement


name: NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial measurement


name: complement C1q and tumor necrosis factor-related protein 9A measurement


name: discoidin, CUB and LCCL domain-containing protein 2 measurement


name: PH and SEC7 domain-containing protein 2 measurement


name: mono [ADP-ribose] polymerase PARP16 measurement


name: CUB and Sushi domain-containing protein 1 measurement


name: ribosyldihydronicotinamide dehydrogenase [quinone] measurement


name: zinc fingers and homeoboxes protein 3 measurement


name: nutritionally-regulated adipose and cardiac enriched protein homolog measurement


name: prostate and testis expressed protein 4 measurement


name: PH and SEC7 domain-containing protein 1 measurement


name: NAD(P)H dehydrogenase [quinone] 1 measurement


name: sodium- and chloride-dependent neutral and basic amino acid transporter B(0+) measurement


name: 2-phosphoxylose phosphatase 1 measurement


name: arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 measurement


name: NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4 measurement


name: v-set and immunoglobulin domain-containing protein 2 measurement


name: CUB and zona pellucida-like domain-containing protein 1 measurement


name: carbonyl reductase [NADPH] 1 measurement


name: arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 measurement


name: arf-GAP domain and FG repeat-containing protein 1 measurement


name: p53 and DNA damage-regulated protein 1 measurement


name: CUB and Sushi domain-containing protein 2 measurement


name: carbonyl reductase [NADPH] 3 measurement


name: gluteofemoral adipose tissue measurement


name: visceral:abdominal adipose tissue ratio measurement


name: visceral:gluteofemoral adipose tissue ratio measurement


name: abdominal:gluteofemoral adipose tissue ratio measurement


name: S-warfarin to R-warfarin ratio measurement


name: S-6-hydroxywarfarin to S-warfarin ratio measurement


name: R-6-hydroxywarfarin to R-warfarin ratio measurement


name: S-7-hydroxywarfarin to S-warfarin ratio measurement


name: RS-10-hydroxywarfarin to RS-warfarin ratio measurement


name: sphingomyelin 43:1/ 34:1 ratio measurement


name: SARS-CoV-2 neutralizing antibody measurement"@e


hoarding disorder"@e

category: biolink:Disease biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:NamedThing biolink:ThingWithTaxon


name: antihyperlipidemic drug use measurement"@e


name: vascular endothelial function measurement"@e


name: photoreceptor cell layer thickness measurement


name: anti-GAD65 autoimmune neurological syndromes"@e


name: blood galactosylceramidase activity measurement"@e


name: multiple sclerosis symptom measurement"@e


name: susceptibility to influenza measurement"@e


name: palmitoleoyl-arachidonoyl-glycerol (16:1/20:4) [2] measurement


name: C38:4 phosphatidylserine plasmalogen measurement


name: C38:3 phosphatidylserine plasmalogen measurement


name: C40:4 phosphatidylserine plasmalogen measurement


name: sphingomyelin (d18:2/21:0, d16:2/23:0) measurement


name: sphingomyelin (d17:2/16:0, d18:2/15:0) measurement


name: sphingomyelin (d18:1/19:0, d19:1/18:0) measurement


name: isoursodeoxycholate sulfate (2) measurement


name: sphingomyelin (d18:0/20:0, d16:0/22:0) measurement


name: C38:4 phosphatidylcholine plasmalogen measurement


name: sphingomyelin (d18:0/18:0, d19:0/17:0) measurement


name: ceramide (d18:2/24:1, d18:1/24:2) measurement


name: lactobacillus phage virus seropositivity


name: streptococcus virus phage virus seropositivity


name: foot-and-mouth disease virus seropositivity


name: respiratory syncytial virus seropositivity


name: skin and soft tissue Staphylococcus aureus infection


name: familial apolipoprotein B hypobetalipoproteinemia


name: idiopathic osteonecrosis of the femoral head


name: chronic rhinosinusitis with nasal polyps


response to stress

category: biolink:BiologicalProcess biolink:BiologicalProcessOrActivity biolink:BiologicalEntity biolink:NamedThing biolink:Occurrent biolink:OntologyClass biolink:ThingWithTaxon biolink:PhysicalEssenceOrOccurrent

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in organismal or cellular homeostasis, usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation).


inflammatory response

description: The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.


sensory perception of sound

description: The series of events required for an organism to receive an auditory stimulus, convert it to a molecular signal, and recognize and characterize the signal. Sonic stimuli are detected in the form of vibrations and are processed to form a sound.


sensory perception of smell

description: The series of events required for an organism to receive an olfactory stimulus, convert it to a molecular signal, and recognize and characterize the signal. Olfaction involves the detection of chemical composition of an organism's ambient medium by chemoreceptors. This is a neurological process.


behavior

description: The internally coordinated responses (actions or inactions) of animals (individuals or groups) to internal or external stimuli, via a mechanism that involves nervous system activity.


circadian rhythm

description: Any biological process in an organism that recurs with a regularity of approximately 24 hours.


response to radiation

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electromagnetic radiation stimulus. Electromagnetic radiation is a propagating wave in space with electric and magnetic components. These components oscillate at right angles to each other and to the direction of propagation.


response to cold

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cold stimulus, a temperature stimulus below the optimal temperature for that organism.


response to xenobiotic stimulus

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a xenobiotic, a compound foreign to the organim exposed to it. It may be synthesized by another organism (like ampicilin) or it can be a synthetic chemical.


response to water

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of water.


response to virus

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a virus.


response to lithium ion

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lithium (Li+) ion stimulus.


response to isoquinoline alkaloid

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an isoquinoline alkaloid stimulus. An isoquinoline alkaloid is any member of a group of compounds with the heterocyclic ring structure of benzo(c)pyridine which is a structure characteristic of the group of opium alkaloids.


ovulation

description: The release of a mature ovum/oocyte from an ovary.


response to methotrexate

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a methotrexate stimulus. Methotrexate is 4-amino-10-methylformic acid, a folic acid analogue that is a potent competitive inhibitor of dihydrofolate reductase.


response to corticosteroid

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a corticosteroid hormone stimulus. A corticosteroid is a steroid hormone that is produced in the adrenal cortex. Corticosteroids are involved in a wide range of physiologic systems such as stress response, immune response and regulation of inflammation, carbohydrate metabolism, protein catabolism, blood electrolyte levels, and behavior. They include glucocorticoids and mineralocorticoids.


response to vitamin

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin stimulus.


response to cytokine

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus.


response to interferon-beta

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-beta stimulus. Interferon-beta is a type I interferon.


response to diuretic

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a diuretic stimulus. A diuretic is an agent that promotes the excretion of urine through its effects on kidney function.


response to methylphenidate

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a methylphenidate stimulus.


response to gemcitabine

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gemcitabine stimulus. Gemcitabine is a 2'-deoxycytidine having geminal fluoro substituents in the 2'-position, and is used as a drug in the treatment of various carcinomas.


response to statin

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a statin stimulus. Statins are organooxygen compounds whose structure is related to compactin (mevastatin) and which may be used as an anticholesteremic drug due its EC:1.1.1.34/EC:1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitory properties.


response to lapatinib

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lapatinib stimulus.


response to 5-fluorouracil

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a 5-fluorouracil stimulus.


response to antidepressant

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antidepressant stimulus, a mood-stimulating drug.


response to anticonvulsant

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an anticonvulsant stimulus, a drug used to prevent seizures or reduce their severity.


response to iloperidone

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an iloperidone stimulus.


odontogenesis

description: The process whose specific outcome is the progression of a tooth or teeth over time, from formation to the mature structure(s). A tooth is any hard bony, calcareous, or chitinous organ found in the mouth or pharynx of an animal and used in procuring or masticating food.


menopause

description: Cessation of menstruation, occurring in (e.g.) the human female usually around the age of 50.


response to morphine

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a morphine stimulus. Morphine is an opioid alkaloid, isolated from opium, with a complex ring structure.


tooth eruption

description: The tooth development process in which the teeth enter the mouth and become visible.


response to antibiotic

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antibiotic stimulus. An antibiotic is a chemical substance produced by a microorganism which has the capacity to inhibit the growth of or to kill other microorganisms.


response to stimulus

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus. The process begins with detection of the stimulus and ends with a change in state or activity or the cell or organism.


sensory perception of taste

description: The series of events required for an organism to receive a gustatory stimulus, convert it to a molecular signal, and recognize and characterize the signal. Gustation involves the direct detection of chemical composition, usually through contact with chemoreceptor cells. This is a neurological process.


sensory perception of bitter taste

description: The series of events required to receive a bitter taste stimulus, convert it to a molecular signal, and recognize and characterize the signal. This is a neurological process.


sensory perception of sweet taste

description: The series of events required to receive a sweet taste stimulus, convert it to a molecular signal, and recognize and characterize the signal. This is a neurological process.


response to glucocorticoid

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects.


positive regulation of ovulation

description: Any process that activates or increases the frequency, rate or extent of ovulation, the release of a mature ovum/oocyte from an ovary.


response to anticoagulant

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an anticoagulant stimulus.


response to aromatase inhibitor

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an aromatase inhibitor stimulus.


name: response to platelet aggregation inhibitor

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a platelet aggregation inhibitor stimulus.


name: response to reverse transcriptase inhibitor

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a reverse transcriptase inhibitor stimulus.


platelet aggregation

description: The adhesion of one platelet to one or more other platelets via adhesion molecules.


response to hydroxyurea

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydroxyurea stimulus.


response to cisplatin

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cisplatin stimulus.


response to topoisomerase inhibitor

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a topoisomerase inhibitor stimulus.


response to antineoplastic agent

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antineoplastic agent stimulus. An antineoplastic agent is a substance that inhibits or prevents the proliferation of neoplasms.


response to carboplatin

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a carboplatin stimulus.


response to antimetabolite

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antimetabolite stimulus. An antimetabolite is a substance which is structurally similar to a metabolite but which competes with it or replaces it, and so prevents or reduces its normal utilization.


response to antipsychotic drug

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antipsychotic drug stimulus. Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect.


response to olanzapine

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an olanzapine stimulus.


response to perphenazine

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a perphenazine stimulus. Perphenazine is a phenothiazine derivative having a chloro substituent at the 2-position and a 3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl group at the N-10 position.


response to quetiapine

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a quetiapine stimulus.


response to risperidone

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a risperidone stimulus.


response to ziprasidone

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ziprasidone stimulus. Ziprasidone is a piperazine compound having 1,2-benzothiazol-3-yl- and 2-(6-chloro-1,3-dihydro-2-oxindol-5-yl)ethyl substituents attached to the nitrogen atoms.


response to clozapine

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a clozapine stimulus.


response to bronchodilator

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a bronchodilator stimulus. A bronchodilator is a chemical that causes an increase in the expansion of a bronchus or bronchial tubes.


response to paracetamol

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a paracetamol stimulus.


response to candesartan

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a candesartan stimulus.


response to fenofibrate

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fenofibrate stimulus.


response to metformin

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a metformin stimulus.


response to ribavirin

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ribavirin stimulus.


response to camptothecin

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a camptothecin stimulus.


response to tamsulosin

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tamsulosin stimulus.


response to cyclophosphamide

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cyclophosphamide stimulus.


response to docetaxel trihydrate

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a docetaxel trihydrate stimulus.


response to doxorubicin

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a doxorubicin stimulus.


response to etoposide

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an etoposide stimulus.


response to 4'-epidoxorubicin

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a 4'-epidoxorubicin stimulus.


response to simvastatin

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a simvastatin stimulus. Simvastatin is a statin used as a cholesterol-lowering and anti-cardiovascular disease drug.


response to acetylsalicylate

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an aspirin (acetylsalicylate) stimulus. Aspirin is a non-steroidal anti-inflammatory drug with moA cyclooxygenase inhibitor activity.


response to clopidogrel

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a clopidogrel stimulus. Clopidogrel is a is an oral, thienopyridine-class antiplatelet agent used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease.


response to haloperidol

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a haloperidol stimulus.


response to temozolomide

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a temozolomide stimulus.


Urinary retention

description: Inability to completely empty the urinary bladder during the process of urination.


Urinary incontinence

description: Loss of the ability to control the urinary bladder leading to involuntary urination.


Inguinal hernia

description: Protrusion of the contents of the abdominal cavity through the inguinal canal.


Abnormality of the genital system

description: An abnormality of the genital system.


Abnormality of the urinary system

description: An abnormality of the urinary system.


Menorrhagia

description: Prolonged and excessive menses at regular intervals in excess of 80 mL or lasting longer than 7 days.


Oral ulcer

description: Erosion of the mucous mebrane of the mouth with local excavation of the surface, resulting from the sloughing of inflammatory necrotic tissue.


Abnormality of the dentition

description: Any abnormality of the teeth.


Gingival bleeding

description: Hemorrhage affecting the gingiva.


Widow's peak

description: Frontal hairline with bilateral arcs to a low point in the midline of the forehead.


Tinnitus

description: Tinnitus is an auditory perception that can be described as the experience of sound, in the ear or in the head, in the absence of external acoustic stimulation.


Abnormality of refraction

description: An abnormality in the process of focusing of light by the eye in order to produce a sharp image on the retina.


Atypical behavior

description: Atypical behavior is an abnormality in a person's actions, which can be controlled or modulated by the will of the individual. While abnormal behaviors can be difficult to control, they are distinct from other abnormal actions that cannot be affected by the individual's will.


Agitation

description: A state of extreme restlessness and excessive motor activity is associated with mental distress or a feeling of inner tension.


Hallucinations

description: Perceptions in a conscious and awake state that, in the absence of external stimuli, have qualities of real perception. These perceptions are vivid, substantial, and located in external objective space.


Hematuria

description: The presence of blood in the urine. Hematuria may be gross hematuria (visible to the naked eye) or microscopic hematuria (detected by dipstick or microscopic examination of the urine).


Cafe-au-lait spot

description: Cafe-au-lait spots are hyperpigmented lesions that can vary in color from light brown to dark brown with smooth borders and having a size of 1.5 cm or more in adults and 0.5 cm or more in children.


Hyperhidrosis

description: Abnormal excessive perspiration (sweating) despite the lack of appropriate stimuli like hot and humid weather.


Pruritus

description: Pruritus is an itch or a sensation that makes a person want to scratch. This term refers to an abnormally increased disposition to experience pruritus.


Hirsutism

description: Abnormally increased hair growth referring to a male pattern of body hair (androgenic hair).


Mental deterioration

description: Loss of previously present mental abilities, generally in adults.


Syncope

description: Syncope refers to a generalized weakness of muscles with loss of postural tone, inability to stand upright, and loss of consciousness. Once the patient is in a horizontal position, blood flow to the brain is no longer hindered by gravitation and consciousness is regained. Unconsciousness usually lasts for seconds to minutes. Headache and drowsiness (which usually follow seizures) do not follow a syncopal attack. Syncope results from a sudden impairment of brain metabolism usually due to a reduction in cerebral blood flow.


Hepatic fibrosis

description: The presence of excessive fibrous connective tissue in the liver. Fibrosis is a reparative or reactive process.


Small for gestational age

description: Smaller than normal size according to sex and gestational age related norms, defined as a weight below the 10th percentile for the gestational age.


Death in infancy

description: Death within the first 24 months of life.


Umbilical hernia

description: Protrusion of abdominal contents through a defect in the abdominal wall musculature around the umbilicus. Skin and subcutaneous tissue overlie the defect.


Bradycardia

description: A slower than normal heart rate (in adults, slower than 60 beats per minute).


Abnormal aortic morphology

description: An abnormality of the aorta.


Abnormal foot morphology

description: An abnormality of the skeleton of foot.


Hallux valgus

description: Lateral deviation of the great toe (i.e., in the direction of the little toe).


Thromboembolism

description: The formation of a blood clot inside a blood vessel that subsequently travels through the blood stream from the site where it formed to another location in the body, generally leading to vascular occlusion at the distant site.


Fever

description: Body temperature elevated above the normal range.


Abnormal thrombosis

description: Venous or arterial thrombosis (formation of blood clots) of spontaneous nature and which cannot be fully explained by acquired risk (e.g. atherosclerosis).


Dysphagia

description: Difficulty in swallowing.


Nausea

description: A sensation of unease in the stomach together with an urge to vomit.


Anorexia

description: Anorexia, or the loss of appetite for food, is a medical condition.


Ischemic stroke

description: Acute ischemic stroke (AIS) is defined by the sudden loss of blood flow to an area of the brain with the resulting loss of neurologic function. It is caused by thrombosis or embolism that occludes a cerebral vessel supplying a specific area of the brain. During a vessel occlusion, there is a core area where damage to the brain is irreversible and an area of penumbra where the brain has lost function owing to decreased blood flow but is not irreversibly injured.


Postural instability

description: A tendency to fall or the inability to keep oneself from falling; imbalance. The retropulsion test is widely regarded as the gold standard to evaluate postural instability, Use of the retropulsion test includes a rapid balance perturbation in the backward direction, and the number of balance correcting steps (or total absence thereof) is used to rate the degree of postural instability. Healthy subjects correct such perturbations with either one or two large steps, or without taking any steps, hinging rapidly at the hips while swinging the arms forward as a counterweight. In patients with balance impairment, balance correcting steps are often too small, forcing patients to take more than two steps. Taking three or more steps is generally considered to be abnormal, and taking more than five steps is regarded as being clearly abnormal. Markedly affected patients continue to step backward without ever regaining their balance and must be caught by the examiner (this would be called true retropulsion). Even more severely affected patients fail to correct entirely, and fall backward like a pushed toy soldier, without taking any corrective steps.


Colonic diverticula

description: The presence of multiple diverticula of the colon.


Headache

description: Cephalgia, or pain sensed in various parts of the head, not confined to the area of distribution of any nerve.


Drowsiness

description: Abnormal feeling of sleepiness or difficulty staying awake.


name: Febrile seizure (within the age range of 3 months to 6 years)

description: A febrile seizure is any type of seizure (most often a generalized tonic-clonic seizure) occurring with fever (at least 38 degrees Celsius) but in the absence of central nervous system infection, severe metabolic disturbance or other alternative precipitant in children between the ages of 3 months and 6 years.


Hematochezia

description: The passage of fresh (red) blood per anus, usually in or with stools. Most rectal bleeding comes from the colon, rectum, or anus.


Lymphadenopathy

description: Enlargment (swelling) of a lymph node.


Arthralgia

description: Joint pain.


Abnormality of chromosome segregation

description: An abnormality of chromosome segregation.


Hypomagnesemia

description: An abnormally decreased magnesium concentration in the blood.


Ketonuria

description: High levels of ketone bodies (acetoacetic acid, beta-hydroxybutyric acid, and acetone) in the urine. Ketone bodies are insignificant in the blood and urine of normal individuals in the postprandial or overnight-fasted state.


Hypoalbuminemia

description: Reduction in the concentration of albumin in the blood.


Glycosuria

description: An increased concentration of glucose in the urine.


Abnormal EKG

description: Abnormal rhythm of the heart.


name: Abnormal circulating lipid concentration

description: Any deviation from the normal concentration of a lipid in the blood circulation.


Hypocholesterolemia

description: An decreased concentration of cholesterol in the blood.


Myalgia

description: Pain in muscle.


Back pain

description: An unpleasant sensation characterized by physical discomfort (such as pricking, throbbing, or aching) localized to the back.


Somatic sensory dysfunction

description: An abnormality of the primary sensation that is mediated by peripheral nerves (pain, temperature, touch, vibration, joint position). The word hypoesthesia (or hypesthesia) refers to a reduction in cutaneous sensation to a specific type of testing.


Ventricular arrhythmia

description: A disorder characterized by an electrocardiographic finding of an atypical cardiac rhythm resulting from a pathologic process in the cardiac ventricles.


Abnormality of the sense of smell

description: An anomaly in the ability to perceive and distinguish scents (odors).


Premature atrial contractions

description: A type of cardiac arrhythmia with premature atrial contractions or beats caused by signals originating from ectopic atrial sites.


Obsessive-compulsive trait

description: The presence of one or more obsessive-compulsive personality traits. Obsessions refer to persistent intrusive thoughts, and compulsions to intrusive behaviors, which the affected person experiences as involuntary, senseless, or repugnant.


Facial wrinkling

description: Excessive wrinkling of the skin of the face.


Attached earlobe

description: Attachment of the lobe to the side of the face at the lowest point of the lobe without curving upward.


Stress urinary incontinence

description: Involuntary urine leakage synchronous with exertion, or actions such as sneezing, or coughing.


Abdominal symptom

description: A subjective manifestation of disease localized to the abdomen.


Right bundle branch block

description: A conduction block of the right branch of the bundle of His. This manifests as a prolongation of the QRS complex (greater than 0.12 s) with delayed activation of the right ventricle and terminal delay on the EKG.


Aspirin-induced asthma

description: A type of asthma in which aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) that inhibit cyclooxygen-ase 1 (COX-1) exacerbate bronchoconstriction.


Drug-induced agranulocytosis

description: A type of agranulocytosis related to ingestion of a specific medication.


Fatigue

description: A subjective feeling of tiredness characterized by a lack of energy and motivation.


Abnormal brain morphology

description: A structural abnormality of the brain, which has as its parts the forebrain, midbrain, and hindbrain.


Brain atrophy

description: Partial or complete wasting (loss) of brain tissue that was once present.


Chronic pain

description: Persistent pain, usually defined as pain that has lasted longer than 3 to 6 months.


Moderate albuminuria

description: The presence of moderately increased concentrations of albumin in the urine, defined as and albumin-creatinine ratio (ACR) of 30 to 299 mg/gm (3.4 to 34 mg/mmol).


Cough

description: A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation.


Bone fracture

description: A partial or complete breakage of the continuity of a bone.


Sneeze

description: A sudden violent, spasmodic, audible expiration of breath through the nose and mouth.


Stiff neck

description: A sensation of tightness in the neck when attempting to move it, especially after a period of inactivity. Neck stiffness often involves soreness and difficulty moving the neck, especially when trying to turn the head to the side.


name: Abnormal cardiovascular system morphology

description: Any structural anomaly of the heart and great vessels.


Modic type vertebral endplate changes

description: An abnormal magnetic resonance tomography signal from a vertebral endplate according to a widely used classification published by Dr. Michael Modic.


Neck pain

description: An unpleasant sensation characterized by physical discomfort (such as pricking, throbbing, or aching) localized to the neck.


Shoulder pain

description: An unpleasant sensation characterized by physical discomfort (such as pricking, throbbing, or aching) localized to the shoulder.


Hip pain

description: An unpleasant sensation characterized by physical discomfort (such as pricking, throbbing, or aching) localized to the hip.


Knee pain

description: An unpleasant sensation characterized by physical discomfort (such as pricking, throbbing, or aching) localized to the knee.


Flushing

description: Recurrent episodes of redness of the skin together with a sensation of warmth or burning of the affected areas of skin.


Non-accomodative esotropia

description: A form of esotropia in which the angle of deviation is not affected by accommodative effort.


Neonatal sepsis

description: Systemic inflammatory response to infection in newborn babies.


Fractured vertebra

description: A partial or complete breakage of the vertebra.


Cognitive impairment

description: Abnormal cognition is characterized by deficits in thinking, reasoning, or remembering.


Arterial stenosis

description: Narrowing or constriction of the inner surface (lumen) of an artery.


Telangiectasia of the skin

description: Presence of small, permanently dilated blood vessels near the surface of the skin, visible as small focal red lesions.


Dysmenorrhea

description: Pain during menstruation that interferes with daily activities.


Metrorrhagia

description: Bleeding at irregular intervals.


Self-injurious behavior

description: Self-aggression.


Hernia

description: The protrusion of part of an organ or fibroadipose tissue through an abnormal opening.


Sepsis

description: Systemic inflammatory response to infection.


Exercise induced anaphylaxis

description: Anaphylaxis after physical activity.


disease

description: A disease is a disposition to undergo pathological processes that exists in an organism because of one or more disorders in that organism.


pelvic organ prolapse

description: Abnormal descent of a pelvic organ resulting in the protrusion of the organ beyond its normal anatomical confines. Symptoms often include vaginal discomfort, dyspareunia; urinary stress incontinence; and fecal incontinence.


transposition of the great arteries

description: A congenital cardiac defect in which two heart vessels are reversed (transposed).


developmental dysplasia of the hip

description: A spectrum of hip abnormalities commonly presenting in infancy involving the relationship between the femoral head and the acetabulum and that includes subluxation or dislocation at rest or upon provocation.


Buruli ulcer disease

description: A cutaneous infection caused by Mycobacterium ulcerans. It presents with painless nodular swelling of the skin, leading to the formation of necrotizing ulcers.


extrapulmonary tuberculosis

description: A tuberculosis that occurs at body sites other than the lung.


first-degree atrioventricular block

description: A disorder characterized by an electrocardiographic finding of prolonged PR interval for a specific population. For adults one common threshold is a PR interval greater than 0.20 seconds.


hypersensitivity reaction disease

description: An immune system disease that has basis in dysregulation of the hypersensitivity reaction, an inflammatory response to an exogenous environmental antigen or an endogenous antigen initiated by the adaptive immune system.


name: progesterone-receptor negative breast cancer


Her2-receptor negative breast cancer

description: A breast adenocarcinoma which is negative for the expression of the HER2 receptor.


microscopic colitis

description: Inflammation of the colon that is only apparent by microscopic examination.


collagenous colitis

description: A type of microscopic colitis of unknown etiology. It is characterized by the presence of collagen deposits in the lamina propria of the colonic mucosa. Patients present with chronic watery diarrhea. Colonoscopy reveals normal-appearing mucosa. The diagnosis is made with the microscopic examination of the colonic biopsy samples.


stutter disorder

description: A speech disorder characterized by frequent sound or syllable repetitions, sound prolongations, or other dysfluencies that are inappropriate for the individual's age.


specific language impairment

description: A language disorder characterized by difficulty in language acquisition despite otherwise normal development and in the absence of any obvious explanatory factors.


ectopic pregnancy

description: An abnormal pregnancy in which the conception is implanted outside the endometrial cavity.


drug allergy

description: Immunologically mediated adverse reactions to medicinal substances used legally or illegally.


childhood acute lymphoblastic leukemia

description: An acute lymphoblastic leukemia occurring during childhood. The majority of cases are B-acute lymphoblastic leukemias. Approximately 15% of the cases are T-acute lymphoblastic leukemias.


Zika virus congenital syndrome

description: A congenital birth syndrome that arises from materal Zika infection.


name: cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1

description: A CADASIL characterized by migraine, strokes, and white matter lesions that has material basis in heterozygous mutation in the NOTCH3 gene on chromosome 19p13.


amblyopia

description: Decreased vision that results from abnormal visual development.


tonsillitis

description: Inflammation of the tonsillar tissue.


gastric cancer

description: A primary or metastatic malignant neoplasm involving the stomach.


essential hypertension

description: Hypertension that presents without an identifiable cause.


borderline personality disorder

description: A disorder characterized by an enduring pattern of unstable self-image and mood together with volatile interpersonal relationships, self-damaging impulsivity, recurrent suicidal threats or gestures and/or self-mutilating behavior.


impulse control disorder

description: A category of behaviors that can be loosely defined as the failure to resist an impulsive act or behavior that may be harmful to self or others.


urinary bladder cancer

description: A primary or metastatic malignant neoplasm involving the bladder.


esophageal varices

description: Abnormally dilated veins of the esophagus.


familial hyperlipidemia

description: An instance of hyperlipidemia (disease) that is caused by an inherited modification of the individual's genome.


selective IgA deficiency disease

description: A dysgammaglobulinemia characterized by low or undetectable serum levels of immunoglobulin class A (IgA). It is the most common primary antibody deficiency. It may be inherited or the reversible sequela of infection or certain drugs. It may be caused by decreased or inefficient class-switching from progenitor B cells without any corresponding decreases in the other isotypes. Though affected persons may be asymptomatic, low levels of IgA will reduce the immune system's ability to combat infection where IgA is normally secreted, at mucosal surfaces. Selective IgA deficiency is seen in greater proportion among patients with autoimmune disorders.


iron deficiency anemia

description: Anemia caused by low iron intake, inefficient iron absorption in the gastrointestinal tract, or chronic blood loss.


degenerative myopia

description: Excessive axial myopia associated with complications (especially posterior staphyloma and choroidal neovascularization) that can lead to blindness.


myopia

description: The condition in which the individual does not see far distances clearly.


primary aldosteronism

description: An endocrine disorder characterized by excessive production of aldosterone by the adrenal glands. Causes include adrenal gland adenoma and adrenal gland hyperplasia. The overproduction of aldosterone results in sodium and water retention and hypokalemia. Patients present with high blood pressure, muscle weakness, and headache.


pulmonary alveolar proteinosis

description: A rare lung disorder characterized by the filling of the pulmonary alveoli with proteinaceous material which stains positive with periodic acid-Schiff stain. It may be idiopathic or secondary due to hematologic malignancies or the inhalation of mineral dusts. Signs and symptoms include dyspnea, cough and low grade fever.


neutropenia

description: A decrease in the number of neutrophils found in the blood.


dysentery

description: Acute inflammation of the intestine associated with infectious diarrhea of various etiologies, generally acquired by eating contaminated food containing toxins, biological derived from bacteria or other microorganisms. Dysentery is characterized initially by watery feces then by bloody mucoid stools. It is often associated with abdominal pain; fever; and dehydration.


hypertrophic pyloric stenosis

description: An abnormality characterized by thickening of the muscle in the wall of the pylorus. It results in the narrowing of the pyloric channel. The overlying mucosa may appear hypertrophic as well. Clinical signs and symptoms appear early in life and include projectile vomiting and dehydration.


acoustic neuroma

description: A type of benign brain tumor that begins in the Schwann cells, which produce the myelin that protects the acoustic nerve - the nerve of hearing.


dementia

description: Loss of intellectual abilities interfering with an individual's social and occupational functions. Causes include Alzheimer's disease, brain injuries, brain tumors, and vascular disorders.


nontoxic goiter

description: Sporadic enlargement of the thyroid gland that is not associated with changes in thyroid function or malignancy.


proliferative diabetic retinopathy

description: Advanced retinopathy due to diabetes mellitus characterized by the formation of new vessels in the retina. The new vessels are abnormal and fragile. If hemorrhage occurs due to the vascular fragility, there is increased risk of vision loss or blindness.


diarrheal disease

description: The condition of having at least three loose or liquid bowel movements each day.


color vision disorder

description: The absence of or defect in the perception of colors.


excessive tearing

description: Profuse lacrimation.


sick sinus syndrome

description: A constellation of signs and symptoms which may include syncope, fatigue, dizziness, and alternating periods of bradycardia and atrial tachycardia, which is caused by sinoatrial node dysfunction.


polyneuropathy

description: A disease or disorder affecting more than one nerve.


primary angle-closure glaucoma

description: An angle-closure glaucoma characterized by closure of the anterior chamber angle by an intrinsic defect such that aqueous outflow is blocked and the intraocular pressure becomes inappropriately elevated leading to optic nerve damage and visual field loss. Primary angle-closure glaucoma has symptom progressive peripheral vision loss, decreased vision, and pain, redness, and headache in acute cases. Primary angle closure glaucoma can be caused by anatomically narrow angle, defects in the trabecular meshwork, and iris abnormalities. Primary angle-closure glaucoma has a strong genetic component.


generalized anxiety disorder

description: An anxiety disorder characterized by excessive and difficult-to-control worry about a number of life situations. The worry is accompanied by restlessness, fatigue, inability to concentrate, irritability, muscle tension, and/or sleep disturbance and lasts for at least 6 months.


major depressive disorder

description: An episode of depression lasting two or more weeks without an intervening episode of mania.


psychiatric disorder

description: A disorder characterized by behavioral and/or psychological abnormalities, often accompanied by physical symptoms. The symptoms may cause clinically significant distress or impairment in social and occupational areas of functioning. Representative examples include anxiety disorders, cognitive disorders, mood disorders and schizophrenia.


candidiasis

description: Infection with the organism Candida.


colon carcinoma

description: A carcinoma that arises from epithelial cells of the colon


head and neck carcinoma

description: A carcinoma that arises from the head and neck region. Representative examples include oral cavity squamous cell carcinoma, laryngeal squamous cell carcinoma, and salivary gland carcinoma.


thrombocytopenia

description: A laboratory test result indicating that there is an abnormally small number of platelets in the circulating blood.


pneumothorax

description: Abnormal presence of air in the pleural cavity.


heart septal defect

description: A congenital disorder characterized by the presence of an abnormal communication between the atria or the ventricles of the heart due to defects in the cardiac septum.


thyroid cancer

description: A malignant neoplasm involving the thyroid gland


cholecystitis

description: An acute or chronic inflammation involving the gallbladder wall. It may be associated with the presence of gallstones.


constipation disorder

description: Irregular and infrequent or difficult evacuation of the bowels.


hepatitis

description: An active inflammatory process affecting the liver for more than six months. Causes include viral infections, autoimmune disorders, drugs, and metabolic disorders.


spondylosis

description: A degenerative spinal disease that can involve any part of the vertebra, the intervertebral disk, and the surrounding soft tissue.


female reproductive system disorder

description: A disease involving the female reproductive system.


anemia

description: A reduction in the number of red blood cells, the amount of hemoglobin, and/or the volume of packed red blood cells. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability.


central nervous system origin vertigo

description: An illusion of movement, either of the external world revolving around the individual or of the individual revolving in space. Vertigo may be associated with disorders of the inner ear (ear, inner); vestibular nerve; brainstem; or cerebral cortex. Lesions in the temporal lobe and parietal lobe may be associated with focal seizures that may feature vertigo as an ictal manifestation. (From Adams et al., Principles of Neurology, 6th ed, pp300-1)


sensory peripheral neuropathy

description: Inflammation or degeneration of the sensory nerves.


chondromalacia

description: Pathological processes involving the chondral tissue (cartilage).


cervicitis

description: An acute or chronic inflammatory process that affects the cervix. Causes include sexually transmitted diseases and bacterial infections. Clinical manifestations include abnormal vaginal bleeding and vaginal discharge.


kidney cancer

description: Primary or metastatic malignant neoplasm involving the kidney.


nasal disorder

description: A disease involving the nose.


bruxism

description: Excessive clenching of the jaw and grinding of the teeth.


endometrial carcinoma

description: A malignant tumor arising from the epithelium that lines the cavity of the uterine body. The vast majority of endometrial carcinomas are adenocarcinomas; squamous cell and adenosquamous carcinomas represent a minority of the cases. Endometrioid adenocarcinoma is the most frequently seen variant of endometrial adenocarcinoma. Uterine bleeding is an initial clinical sign. The prognosis depends on the stage of the tumor, the depth of myometrial wall invasion, and the degree of differentiation.


glomerulonephritis

description: A renal disorder characterized by damage in the glomeruli. It may be acute or chronic, focal or diffuse, and it may lead to renal failure. Causes include autoimmune disorders, infections, diabetes, and malignancies.


substance abuse

description: The use of a drug for a reason other than which it was intended or in a manner or in quantities other than directed.


acute kidney failure

description: Sudden and sustained deterioration of the kidney function characterized by decreased glomerular filtration rate, increased serum creatinine or oliguria.


substance-related disorder

description: A category of psychiatric disorders which include disorders related to the taking of a drug of abuse (including alcohol, prescribed medications and recreational drugs).


anus disorder

description: A non-neoplastic or neoplastic disorder that affects the anal canal or anal margin. Representative examples of non-neoplastic disorders include hemorrhoids and anal ulcer. Representative examples of neoplastic disorders include carcinoma, lymphoma, and melanoma.


skin neoplasm

description: A benign or malignant tumor involving the skin. Representative examples of benign skin neoplasms include the benign melanocytic skin nevus, acanthoma, sebaceous adenoma, sweat gland adenoma, lipoma, hemangioma, fibroma, and benign fibrous histiocytoma. Representative examples of malignant skin neoplasms include basal cell carcinoma, squamous cell carcinoma, melanoma, and Kaposi sarcoma.


bone osteosarcoma

description: A usually aggressive malignant bone-forming mesenchymal neoplasm arising from the bone. It may arise de novo or from a pre-existing lesion of the bone. Pain and a palpable mass are the most frequent clinical sign and symptom. It may spread to other anatomic sites, particularly the lungs.


central nervous system cancer

description: A malignant neoplasm involving the central nervous system


uterine cancer

description: Primary or metastatic malignant neoplasm involving the uterine corpus and/or the cervix.


pulmonary fibrosis

description: Chronic progressive interstitial lung disorder characterized by the replacement of the lung tissue by connective tissue, leading to progressive dyspnea, respiratory failure, or right heart failure. Causes include chronic inflammatory processes, exposure to environmental irritants, radiation therapy, autoimmune disorders, certain drugs, or it may be idiopathic (no identifiable cause).


heart valve disorder

description: A disease involving the cardial valve.


intracranial thrombosis

description: Formation or presence of a blood clot (thrombus) in a blood vessel within the skull. Intracranial thrombosis can lead to thrombotic occlusions and brain infarction. The majority of the thrombotic occlusions are associated with atherosclerosis.


cervical cancer

description: A primary or metastatic malignant neoplasm involving the cervix.


macular degeneration

description: Loss of vision in the central portion of the retina (macula), secondary to retinal degeneration.


rhinitis

description: An inflammation of the mucous membrane lining the nose, usually associated with nasal discharge.


extrahepatic bile duct carcinoma

description: A carcinoma that arises from epithelial cells of the extrahepatic bile duct.


alcoholic pancreatitis

description: Acute or chronic inflammation of the pancreas due to excessive alcohol drinking. Alcoholic pancreatitis usually presents as an acute episode but it is a chronic progressive disease in alcoholics.


ovarian cyst

description: A cyst that arises from the ovary. Representative examples include simple, complex, corpus luteum, and endometrioid cysts. Symptoms include pelvic and abdominal pain and irregular periods.


dental pulp disorder

description: A disease involving the dental pulp.


strabismus

description: Strabismus is the intermittent or constant misalignment of an eye so that its line of vision is not pointed at the same object as the other eye. Strabismus is caused by an imbalance in the extraocular muscles which control the positioning of the eyes. Strabismus is normal in newborns but should resolve by the time the baby is 6 months old. In older children with strabismus, the brain may learn to ignore the input from one eye, and this may lead to amblyopia, a potentially permanent decrease in vision in that eye if not corrected.


optic atrophy

description: A disorder characterized by loss of optic nerve fibers. It may be inherited or acquired. Acquired causes include ischemia, optic nerve neuropathy, glaucoma, trauma, radiation, brain tumors, and multiple sclerosis. It leads to vision disturbances.


proteinuria

description: The presence of abnormal amounts of protein in the urine.


esophageal disorder

description: A non-neoplastic or neoplastic disorder that affects the esophagus. Representative examples of non-neoplastic disorders include esophagitis and esophageal ulcer. Representative examples of neoplastic disorders include carcinomas, lymphomas, and melanomas.


acute stress disorder

description: An anxiety disorder precipitated by an experience of intense fear or horror while exposed to a traumatic (especially life-threatening) event. The disorder is characterized by dissociative symptoms; vivid recollections of the traumatic event; avoidance of stimuli associated with the traumatic event; and a constant state of hyperarousal for no more than one month.


bronchitis

description: An acute or chronic inflammatory process affecting the bronchi.


lymphopenia

description: Reduction in the number of lymphocytes.


gastric cardia carcinoma

description: A carcinoma that arises from epithelial cells of the cardia of stomach.


muscle tissue disorder

description: A disease involving the muscle tissue.


dental enamel hypoplasia

description: Deficiency in the enamel tissue that results in the formation of grooves, pits, or dents on the surface of the affected teeth.


diverticulitis

description: An infection that develops in the diverticula of the intestinal tract. Signs and symptoms include abdominal pain, fever, and leukocytosis.


peptic ulcer disease

description: A digestive system disease characterized by discontinuation in the inner lining of the gastrointestinal (GI) tract because of gastric acid secretion or pepsin.


digestive system disorder

description: A disease or disorder that involves the digestive system.


hyperthyroidism

description: Overactivity of the thyroid gland resulting in overproduction of thyroid hormone and increased metabolic rate. Causes include diffuse hyperplasia of the thyroid gland (Graves' disease), single nodule in the thyroid gland, and thyroiditis. The symptoms are related to the increased metabolic rate and include weight loss, fatigue, heat intolerance, excessive sweating, diarrhea, tachycardia, insomnia, muscle weakness, and tremor.


myocarditis

description: Myocarditis is a condition that is characterized by inflammation of the heart muscle (myocardium). Some affected people have no noticeable symptoms of the condition. When present, signs and symptoms may include chest pain, abnormal heartbeat, shortness of breath, fatigue, signs of infection (i.e. fever, headache, sore throat, diarrhea), and leg swelling. Myocarditis can be caused by a variety of factors including infections (viral, bacterial, parasitic, and fungal), allergic reactions to certain medications, and exposure to certain chemicals. It can also be associated with other inflammatory conditions such as lupus, Wegener's granulomatosis, giant cell arteritis and Takayasu's arteritis. Most cases occur sporadically in people with no family history of the condition. Treatment aims to address the underlying cause of the condition. Medications and rarely, a heart transplant may be needed if the heart muscle becomes weak.


oropharynx cancer

description: A primary or metastatic malignant neoplasm that affects the oropharynx.


phlebitis

description: Inflammation of a vein.


Hodgkin's lymphoma, mixed cellularity

description: A subtype of classical Hodgkin lymphoma with scattered Reed-Sternberg and Hodgkin cells in a diffuse or vaguely nodular mixed inflammatory background without nodular sclerosing fibrosis. (WHO, 2008)


skin carcinoma in situ

description: A in situ carcinoma that involves the zone of skin.


name: nodular sclerosis classical Hodgkin lymphoma

description: A subtype of classical Hodgkin lymphoma characterized by collagen bands that surround at least one nodule, and Hodgkin and Reed-Sternberg cells with lacunar type morphology. (WHO, 2008)


plantar fibromatosis

description: A superficial fibromatosis arising from soft tissue of the plantar regions. It is characterized by the presence of spindle-shaped fibroblasts, hypercellularity, and an infiltrative growth pattern.


priapism

description: Persistent and usually painful erection that lasts for at least four hours in the absence of physical or psychological stimulation, which can be caused by hematologic disorders, including sickle cell disease and leukemia, spinal cord injuries, and medications.


cleft lip

description: A congenital abnormality consisting of one or more clefts (splits) in the upper lip, which may be accompanied by a cleft palate; it is the result of the failure of the embryonic parts of the lip to fuse.


acute myocardial infarction

description: Necrosis of the myocardium, as a result of interruption of the blood supply to the area. It is characterized by a severe and rapid onset of symptoms that may include chest pain, often radiating to the left arm and left side of the neck, dyspnea, sweating, and palpitations.


fatty liver disease

description: A reversible condition wherein large vacuoles of triglyceride fat accumulate in liver cells via the process of steatosis.


bronchiectasis

description: Segmental, irreversible dilation of the bronchial tree resulting in the accumulation of secretions which leads to obstruction. The most common cause is bacterial infection.


pathologic nystagmus

description: Involuntary movements of the eyeballs. The presence or absence of nystagmus is often used in the diagnosis of a variety of neurological and visual disorders.


placental abruption

description: Vaginal bleeding preceding the 20th week of gestation.


senile cataract

description: A cataract with no obvious cause occurring in persons over 50 years old.


pulmonary emphysema

description: A subcategory of chronic obstructive pulmonary disease (COPD). It occurs in people who smoke and suffer from chronic bronchitis. It is characterized by inflation of the alveoli, alveolar wall damage, and reduction in the number of alveoli, resulting in difficulty breathing.


upper respiratory tract disorder

description: A disease involving the upper respiratory tract.


hemorrhoid

description: Dilated veins in the anal canal.


hyperopia

description: A refractive error in which rays of light entering the eye parallel to the optic axis are brought to a focus behind the retina, as a result of the eyeball being too short from front to back. It is also called farsightedness because the near point is more distant than it is in emmetropia with an equal amplitude of accommodation. (Dorland, 27th ed)


refractive error

description: A defect in the focusing of light on the retina as in astigmatism, myopia, or hyperopia.


accommodative esotropia

description: A form of esotropia (convergent deviation of the eyes) associated with activation of the accommodative reflex.


esotropia

description: A form of strabismus in which one or both eyes are deviated medially.


alopecia

description: Hair loss usually from the scalp. It may result in bald spots or spread to the entire scalp or the entire epidermis. It may be androgenetic or caused by chemotherapeutic agents, compulsive hair pulling, autoimmune disorders or congenital conditions.


mitral valve prolapse

description: A fairly common and often benign valvular heart disorder characterized by redundancy or hooding of mitral valve leaflets so that they prolapse into the left atrium, often causing mitral regurgitation. It is often a symptomless condition but may be marked by varied symptoms (e.g. chest pain, fatigue, dizziness, dyspnea, or palpitations) leading in some cases to endocarditis or ventricular tachycardia.


B-cell acute lymphoblastic leukemia

description: A neoplasm of lymphoblasts committed to the B-cell lineage, typically composed of small to medium-sized blast cells. When the neoplasm involves predominantly the bone marrow and the peripheral blood, it is called B acute lymphoblastic leukemia. When it involves nodal or extranodal sites, it is called B lymphoblastic lymphoma. (WHO, 2001)


B-cell chronic lymphocytic leukemia

description: B-cell chronic lymphocytic leukemia (B-CLL) is a type of B-cell non-Hodgkin lymphoma, and the most common form of leukemia in Western countries, affecting elderly adults (mean age of 67 and 72 years) with a slight male predominance (1.7:1), and characterized by a highly variable clinical presentation that can include asymptomatic disease or non-specific B-symptoms such as unintentional weight loss, severe fatigue, fever (without evidence of infection), and night sweats as well as cervical lymphadenopathy, splenomegaly and frequent infections. Some patients can also develop autoimmune complications such as autoimmune hemolytic anemia or immune thrombocytopenia. The clinical course is extremely heterogeneous with survival ranging from a few months to several decades.


neoplasm of mature B-cells

description: A neoplasm of follicle center B cells which has at least a partial follicular pattern. Follicular lymphomas comprise about 35% of adult non-Hodgkin lymphomas in the U.S. and 22% worldwide. Most patients have widespread disease at diagnosis. Morphologically, follicular lymphomas are classified as Grade 1, Grade 2, and Grade 3, depending on the percentage of the large lymphocytes present. The vast majority of cases (70-95%) express the BCL-2 rearrangement [t(14;18)]. Histological grade correlates with prognosis. Grades 1 and 2 follicular lymphomas are indolent and grade 3 is more aggressive (adapted from WHO, 2001).


gastric carcinoma

description: A carcinoma that arises from epithelial cells of the stomach.


Hodgkins lymphoma

description: Hodgkin lymphoma (HL) is a heterogeneous group of malignant lymphoid neoplasms of B-cell origin characterized histologically by the presence of Hodgkin and Reed-Sternberg (HRS) cells in the vast majority of cases. There are two distinct subtypes: nodular lymphocyte predominant Hodgkin lymphoma and classical Hodgkin lymphoma. Hodgkin lymphoma involves primarily lymph nodes.


monoclonal gammopathy

description: A condition characterized by the abnormal presence of monoclonal immunoglobulins in the blood or urine.


gastritis

description: Inflammation of the stomach.


acute lymphoblastic leukemia

description: Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.


Alzheimer disease

description: A progressive, neurodegenerative disease characterized by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.


amyotrophic lateral sclerosis

description: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive muscular paralysis reflecting degeneration of motor neurons in the primary motor cortex, corticospinal tracts, brainstem and spinal cord.


asthma

description: A bronchial disease that is characterized by chronic inflammation and narrowing of the airways, which is caused by a combination of environmental and genetic factors resulting in recurring periods of wheezing (a whistling sound while breathing), chest tightness, shortness of breath, mucus production and coughing. The symptoms appear due to a variety of triggers such as allergens, irritants, respiratory infections, weather changes, exercise, stress, reflux disease, medications, foods and emotional anxiety.